BEIJING, Sept. 8 -- China's self-developed heart stent has won recognition from the international medical community, with its clinical trial results published online in the world-leading medical journal The Lancet earlier this week.
Named Firehawk, the drug-eluting stent was developed by MicroPort Scientific Corporation, a Chinese healthcare company, to treat patients with coronary artery disease.
The metal stent is 86 microns thick, which is roughly the diameter of a human hair. It contains drugs in micro grooves engraved by lasers on the surface, which prevents the drug from leaking during the transportation of the stent.
Clinical trials were conducted in 21 hospitals in 10 European countries from December 2017 to October 2016. Altogether 1,653 patients from the UK, France, Spain, Italy, Belgium, the Netherlands, Poland, Germany, Austria, and Denmark were implanted with the stent.
According to William Wijns, a professor from the National University of Ireland Galway who led the clinical study, this is the first time that China's medical device went through randomized clinical trials in Europe at such a scale.
Results showed that the safety and clinical efficacy of this stent could rival the Xience stent, one of the world's leading drug-eluting stents.
In addition, its unique structure design could save drug dosages, which help prevent side effects such as thrombus after implantation.
According to Chang Zhaohua, CEO of MicroPort Scientific Corporation, they conducted the clinical trial to further test the stent and compare the results with world-leading heart stents.
"The clinical program adopted European medical standards and was operated by European authoritative experts. We hope to win wider recognition from the international medical community," Chang said.
He said this is the first time that clinical data from a China manufactured stent has been published in such a prestigious medical journal.
"The Lancet is very strict about publishing articles, and the review cycle often lasts for months, sometimes even more than a year. It took less than a month for the journal to publish the clinical trial of the stent, and all five peer review experts gave positive feedback," Chang said.
"With its clinical results being validated in such a rigorous peer-reviewed publication, clinicians and patients may have more confidence in the safety and efficacy of the stent," he added.
According to statistics from the National Cardiovascular Center, there were 290 million cardiovascular patients in China in 2017, including 11 million patients with coronary heart disease.
China has a huge demand for medical devices such as heart stents. The market used to be dominated by costly foreign products.
Many Chinese healthcare companies have increased their research and development in high-end medical devices, making them more affordable to the public.
In addition to the heart stent, Chinese companies are making significant progress in developing cost-effective medical devices such as heart pacemakers and automatic protein analyzers.
"We hope the Firehawk stent can help cure more patients on a global scale. We also want to boost Chinese people's confidence in domestic medical products," Chang said.
美新总统引发抗议
英语六级范文:毕业后的抉择
成功进入面试需避免的10个小失误
英语聊天千万别踩这四大雷区
诗歌欣赏:拜伦《恨别》
保研英语自我介绍范文
英文诗欣赏:花之歌
美文赏析:致忧伤的你
妈妈是最美丽的人Mother Is the Most Beautiful Person
5个耗尽精力的行为
明媚的午后 Bright Afternoon
美文欣赏:善行无小事
英语四级范文:自私和贪婪
高效学习方法
个人鉴定怎么写?
《黑镜》追剧笔记之秘密的代价
英语美文:让优秀成为一种习惯
散文欣赏(汉译英):茅盾《黄昏》
名言集锦(关于毕业)
提问小技巧让你的面试锦上添花
观后感:孤独的灵魂 The Lonely Soul
英语自我介绍范文参考
机器将代替人? Will Robot Take the Place of Men
散文欣赏(汉译英):朱自清《荷塘月色》
话题:网络谣言 Oline Rumors
古文英用:《闲情偶记》翻译
英语自我介绍:如何概括性格特征
散文欣赏(汉译英):什么是朋友
三招教你学好英语口语
英语角话题:聊聊电影
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |